Sernova Corp. (TSE:SVA – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.18 and last traded at C$0.19, with a volume of 1500 shares. The stock had previously closed at C$0.18.
Sernova Stock Down 2.7 %
The firm has a market capitalization of C$60.57 million, a price-to-earnings ratio of -1.74 and a beta of 1.35. The stock has a fifty day moving average of C$0.20 and a two-hundred day moving average of C$0.23. The company has a debt-to-equity ratio of -4.40, a current ratio of 0.32 and a quick ratio of 18.11.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Further Reading
- Five stocks we like better than Sernova
- Why Are These Companies Considered Blue Chips?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Consumer Staples Stocks, Explained
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Profitably Trade Stocks at 52-Week Highs
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
